Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT00762333 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Circulating Markers for Ischemic Heart Disease

StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Re-verified, no change to tracked fieldsv18
  2. Primary and study completion dates: Mar 2026 to Mar 2027v17
  3. Primary and study completion dates: Mar 2022 to Mar 2026v16
  4. Primary and study completion dates: Dec 2020 to Mar 2022v15
  5. Primary and study completion dates: Jun 2020 to Dec 2020v14
Show 12 earlier versionsHide 12 earlier versions
  1. Re-verified, no change to tracked fieldsv13
  2. Primary and study completion dates: Jun 2017 to Jun 2020v12
  3. Primary and study completion dates: Jun 2013 to Jun 2017
    • Enrollment target: 500 to 550
    v11
  4. Primary and study completion dates: Jun 2012 to Jun 2013v10
  5. Re-verified, no change to tracked fieldsv9
  6. Eligibility criteria expanded, about 5 wordsv8
  7. Eligibility criteria revised
    • Study description expanded, about 1 word
    v7
  8. Primary and study completion dates: Jun 2010 to Jun 2012v6
  9. Re-verified, no change to tracked fieldsv5
  10. Enrollment target: 150 to 500v4
  11. 2 versions Re-verified since Oct 7, 2008, no change to tracked fieldsv2-v3
  1. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
UConn Health
38 trials monitored
See 2 trials at risk
Heart Disease
8,786 trials monitored
See 412 trials at risk
Heart Failure
1,995 trials monitored
See 111 trials at risk
The purpose of this research is to determine if two proteins in the blood are increased during acute myocardial infarction and whether their levels are higher in those who develop heart failure than those who do not. These two proteins are produced and potentially released when the heart muscle is damaged. They may then be released into the blood and be detected by standard method in the research laboratory. At this time, detection of an increase in these proteins in the blood is not known to be associated with any disease or myocardial infarction.
Trial Details
NCT Number NCT00762333
Lead Sponsor UConn Health
Conditions
(from sponsor)		 Myocardial Infarction, Ischemia, Congestive Heart Failure
Related terms Heart Failure, Ischemia, Myocardial Infarction
Enrollment 550 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov